Triptorelin Acetate is a peptide formulation for injection that was initially developed and continues to be used mainly in the treatment of advanced metastatic prostate cancer. Additional indications developed subsequently include the treatment of uterine fibroids (a benign tumour of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilisation).
This report contains market size and forecasts of Triptorelin Acetate in global, including the following market information:
Global Triptorelin Acetate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Triptorelin Acetate Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Triptorelin Acetate companies in 2021 (%)
The global Triptorelin Acetate market was valued at 572.1 million in 2021 and is projected to reach US$ 768.5 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.1 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Triptorelin Acetate include Ipsen, Ferring, Chengdu Tiantaishan, TECNOFARMA and Changchun Gensci, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Triptorelin Acetate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Triptorelin Acetate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Triptorelin Acetate Market Segment Percentages, by Type, 2021 (%)
0.1 mg
3 mg
11.25 mg
Global Triptorelin Acetate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Triptorelin Acetate Market Segment Percentages, by Application, 2021 (%)
Male Disease
Female Disease
Global Triptorelin Acetate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Triptorelin Acetate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Triptorelin Acetate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Triptorelin Acetate revenues share in global market, 2021 (%)
Key companies Triptorelin Acetate sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Triptorelin Acetate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ipsen
Ferring
Chengdu Tiantaishan
TECNOFARMA
Changchun Gensci